Logo
Login
$FBIO
$1.93 +$0.06 (3.21%) Close

Company Executives

$FBIO Management Team

Mr. Michael Weiss

Executive Vice Chairman - Strategic Development

Director

Age 59
Compensation $1.230M USD
Sex Male

Ms. Jaclyn Jaffe

Investor Relations

Age -
Compensation -
Sex Female

Dr. Lindsay Rosenwald

Executive Chairman of the Board

President

Chief Executive Officer

Age 70
Compensation $1.380M USD
Sex Male

Mr. David Jin

Chief Financial Officer and Head of Corporate Development

Age 35
Compensation $2.334M USD
Sex Male

Dr. Lucy Lu

Chief Strategy Officer

Age 50
Compensation $40.03K USD
Sex Female

Board of Directors

From the proxy statement filed Apr 28, 2026
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
Not stated
from year joined
CEO also chairs the board
No
Rosenwald
Director Age On board Independent Committees Other public boards Pay Source
Rosenwald
Board chair
 Not stated Not stated Not stated None stated None stated Not stated
Weiss
Executive officer
 Not stated Not stated Not stated None stated None stated Not stated
Hoenlein
Not stated Not stated Not stated None stated None stated Not stated
Klein
Not stated Not stated Not stated None stated None stated Not stated
Lobell
Not stated Not stated Not stated None stated None stated Not stated
Lorenz
Not stated Not stated Not stated None stated None stated Not stated
Harvey
Not stated Not stated Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

4 disclosed in the proxy filed Apr 28, 2026
TGTX
The Company's Executive Vice Chairman, Strategic Development, is the Executive Chairman and Chief Executive Officer of TGTX.
$0.8 million and $0.9 million

Shared services agreement under which TGTX reimbursed the Company for salary and benefit costs of shared research and development employees; the Company invoiced TGTX for these amounts.

With the Company Open in proxy
TGTX
The Company's Executive Vice Chairman, Strategic Development, is the Executive Chairman and Chief Executive Officer of TGTX.
Amount not stated
2025 and 2024

Desk share agreement for New York office space under which TGTX paid a share of rent; the Company paid rent and invoiced TGTX for its prorated share.

With the Company Open in proxy
Journey
The Company's Executive Chairman and Chief Executive Officer is the Executive Chairman of Journey.
Approximately $43,000 and $38,000
2025 and 2024

Shared services arrangement under which Journey reimburses the Company for salary and benefit costs of shared employees and certain other costs; the Company's employees provided services to Journey.

With the Company Open in proxy
Dr. Lucy Lu
Previously a member of the Company's Board of Directors; became the Company's Chief Strategy Officer effective April 15, 2025.
$292,923
2025

Offer letter as Chief Strategy Officer; base salary earned in 2025, plus a signing bonus and an RSU grant.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans